Sub Banner Image

Merck to Buy Cidara in $9.2 Billion Deal as Sales Drop Looms

Markets

Gerry Smith, Frank Connelly

·

November 14, 2025

·

Bloomberg

Merck & Co. agreed to acquire Cidara Therapeutics Inc., a biotech company developing a flu treatment, as part of its ongoing efforts to make up for the upcoming patent loss of its blockbuster cancer drug Keytruda.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.